[Circadian chronotherapy for metastatic liver tumor].
Efficacy of circadian chronotherapy for liver metastases from colorectal cancer was evaluated. Chronomodulated infusion of anticancer drugs via the hepatic artery(HAI) was applied for patients with marginally resectable or unresectable liver metastases at initial diagnosis. Response rate of chemotherapy and frequency of liver resection after chemotherapy of patients treated with chronomodulated HAI were higher than those treated with flat HAI. Further, combination of chronomodulated regional HAI and systemic chemotherapy was the most effective prehepatectomy chemotherapy for the treatment of patients with advanced colorectal liver metastases. Based on these results, we are now performing phase II non-randomized open labeled trial of chronomodulated HAI with systemic administration of panitumumab for patients with such advanced liver metastases (ccFLAP trial). Circadian chronotherapy is an effective prehepatectomy chemotherapy for the treatment of patients with advanced and aggressive liver metastases from colorectal cancer.
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine.
Kuniya
K
Tanaka
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine.
Yasuhiro
Y
Yabushita
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine.
Kazuya
K
Nakagawa
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine.
Itaru
I
Endo
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D019454:Chronotherapy / Q000379:methods; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery
D000970:Antineoplastic Agents